These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14512176)

  • 1. The enhancement of T cell proliferation by L-dopa is mediated peripherally and does not involve interleukin-2.
    Carr L; Tucker A; Fernandez-Botran R
    J Neuroimmunol; 2003 Sep; 142(1-2):166-9. PubMed ID: 14512176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells.
    Carr L; Tucker A; Fernandez-Botran R
    J Neuroimmunol; 2003 Apr; 137(1-2):87-93. PubMed ID: 12667651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired T-dependent immune response in L-dopa treated BALB/c mice.
    Boukhris W; Kouassi E; Descotes J; Cordier G; Revillard JP
    J Clin Lab Immunol; 1987 Aug; 23(4):185-9. PubMed ID: 2959786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
    Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
    Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure effects of 1 and 3 MHz therapeutic ultrasound on ConA activated spleenocytes.
    Johns LD; Colloton P; Neuenfeldt J; Krupo K
    Cytokine; 2003 May; 22(3-4):55-61. PubMed ID: 12849703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "In vivo" activated splenic T cells are refractory to interleukin 2 growth "in vitro".
    Bandeira A; Larsson EL; Forni L; Pereira P; Coutinho A
    Eur J Immunol; 1987 Jul; 17(7):901-8. PubMed ID: 3111860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 receptor expression and function following thermal injury.
    O'Riordain DS; Mendez MV; Holzheimer RG; Collins K; Mannick JA; Rodrick ML
    Arch Surg; 1995 Feb; 130(2):165-70. PubMed ID: 7848087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes.
    Germann T; Schmitt E; Huhn H; Rüde E
    Eur J Immunol; 1988 Mar; 18(3):459-65. PubMed ID: 3128448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine requirement of proliferating T lymphocytes.
    Yaqoob P; Calder PC
    Nutrition; 1997; 13(7-8):646-51. PubMed ID: 9263257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressive activity of pseudolaric acid B on T lymphocytes in vitro.
    Wei N; Li T; Chen H; Mei X; Cao B; Zhang YY
    Phytother Res; 2013 Jul; 27(7):980-5. PubMed ID: 22893196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of interleukins in synergistic effect of Bu-WSA on concanavalin A-induced DNA synthesis in mouse splenic lymphocytes.
    Nitta T; Konno-Ejiri H; Nemoto K; Okumura S; Ozawa A; Nakano M
    Scand J Immunol; 1986 Sep; 24(3):297-305. PubMed ID: 3489286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3',5'-cyclic adenosine monophosphate accumulation.
    DosReis GA; Nóbrega AF; de Carvalho RP
    Cell Immunol; 1986 Aug; 101(1):213-31. PubMed ID: 3017570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of human T lymphocyte proliferation by IL-4.
    Mitchell LC; Davis LS; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in T lymphocyte activity following chemical sympathectomy in young and old Fischer 344 rats.
    Madden KS; Stevens SY; Felten DL; Bellinger DL
    J Neuroimmunol; 2000 Mar; 103(2):131-45. PubMed ID: 10696908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion.
    Ertesvag A; Engedal N; Naderi S; Blomhoff HK
    J Immunol; 2002 Nov; 169(10):5555-63. PubMed ID: 12421932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal T-lymphocyte proliferation and cytotoxic responses induced by a neonatal injection of hydrocortisone: normalization by interleukin-2 addition.
    Ezine S; Papiernik M
    Int J Immunopharmacol; 1984; 6(2):125-32. PubMed ID: 6610654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of temperature and oleic acid on murine memory and virgin T cell activation: interleukin-2 secretion and interleukin-2 receptor expression.
    Wooten RM; Clem LW; Bly JE
    Cell Immunol; 1993 Nov; 152(1):35-48. PubMed ID: 8242770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.